第一线治疗如何改变非移植符合条件的多发性骨髓瘤患者
Francesca Fazio1, Luca Deiana2, Cristian Loi2
1Ematologia - Dipartimento di Medicina Traslazionale e di Precisione - Azienda ospedaliera Universitaria Policlinico Umberto I, Università Sapienza di Roma.
Mediterranean journal of hematology and infectious diseases
|March 14, 2025
概括
新的多发性骨髓瘤治疗方法,包括CD38单克隆抗体和CAR-T疗法,改善了非移植患者的治疗结果. 脆弱性评估有助于个性化护理,减少毒性并提高这一复杂的患者群体的生存率.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
背景情况:
- 多发性骨髓瘤治疗已取得进展,但许多患者无法接受移植.
- 对非移植合格患者的治疗是具有挑战性的,因为疾病的异质性和有限的选择.
- 脆弱的概念越来越被认为是定制老年人治疗的关键.
研究的目的:
- 审查最近多发性骨髓瘤治疗不适合移植的患者的进展.
- 突出脆弱性评估在个性化治疗策略中的作用.
- 讨论新的治疗方法及其对患者结果的影响.
主要方法:
- 对多发性骨髓瘤治疗策略的当前文献的综述.
- 对脆弱性评估对治疗适应性的影响分析.
- 评估新型疗法,包括单克隆抗体,四重疗法和细胞导向疗法.
主要成果:
- CD38单克隆抗体组合,如达拉图穆马布-莱纳利多米德-德甲,显示出明显的无进展和整体生存益处.
- 脆弱性评估允许优化治疗计划和剂量,减少副作用和毒性.
- 新兴疗法,如双特异性抗体和CAR-T治疗,显示出高疗效和最小的残留疾病负面影响.
结论:
- 包括脆弱性评估在内的个性化治疗方法对于非移植资格的多发性骨髓瘤患者至关重要.
- 新型组合和细胞导向疗法正在改变结果,并可能扩大对密集治疗的资格.
- 这些进步提供了深刻而持久的结果,改善了生存率和生活质量.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.0K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.4K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Bone Marrow Sampling and Transplants
269
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
269
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
